CROSS-BORDER COMMERCIALIZATION PLATFORM

Everything you need to know before you decide

Market entry decisions shouldn't be a leap of faith. Here's the reference data, timelines, and coverage we draw on to answer the question every client asks first: is this worth it, and how long will it take?

MARKET EVALUATION & DECISION-MAKING

The knowledge and data you get

Before you commit to a market, you should know exactly what you're walking into. This is the standard set of answers we deliver at the evaluation stage.

Market size
Competitors and possible niches
Sales forecast
Pricing
Regulatory requirements and limitations
Product category & registration possibility
Registration process and most valuable options
Registration costs
Marketing strategy and expenses
Fulfilment costs
Possibility to be registered & product category
Overall risk assessment
QUICK REFERENCE

Fast and easy registration — KSA vs UAE

Approximate time frames from the authorities. Actual timing depends on documentation completeness — our team helps evaluate all gaps upfront.

KSA
Classification2–10 working days
Cosmetics registration3 weeks
Food supplement (advanced food)2–12 weeks
UAE
Classification2–10 working days
Cosmetics & personal care, fragrancesup to 22 working days
Health supplementsup to 12 working days
Detergentsup to 5 working days
Biocidesup to 3 working days
GLOBAL DATA, LOCAL REACH

We hold registration data across 20+ countries

120K medicines in our database from GCC
governmental registries
AustriaBelgiumIceland SpainHungaryMalta NetherlandsRomaniaCroatia GermanyRussiaItaly PortugalDenmarkFinland NorwaySwedenPoland GCC (6)Czech Rep.Slovakia
Why this matters: when a client asks "has this molecule been registered anywhere comparable?", we usually already know the answer — because we scout and expand this database daily, tracking demanded generics and innovative molecules across every market we cover.
PRODUCT POTENTIAL AND RISKS

What we've learned from 480+ registrations

480+ SKUs registered by the GCC authorities in our portfolio

The economic potential is massive — the market has a short supply on many important molecules. Our first step is always a portfolio analysis, so clients register only the products with maximum market potential.

Where the real risk sits

The risk is almost always about the dossier — whether it's compiled to local requirements. We recommend the scientific office route once you already have sales history and several products registered; if you're just starting out, a distributor or SO-agent model is faster and more financially efficient.

Ready to unlock new possibilities?

Let's build your cross-border success story together.

Email us